Description
Recombinant monoclonal antibody to CD45R. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma RA3-6B2. This chimeric mouse antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques.
Target
CD45R
Target Alias Names
B220, CD45, CD45 antigen, Cluster designation 45R, L-CA, Leukocyte common antigen, Ly-5, lymphocyte antigen 5, lymphocyte common antigen, Lyt-4, protein tyrosine phosphatase, receptor type, C, protein tyrosine phosphatase, receptor type, c polypeptide, Receptor-type tyrosine-protein phosphatase C, T200, T200 glycoprotein, T200 leukocyte common antigen
Isotype/Mimetic
IgG2a
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression